Global Patient-derived Xenograft (PDX) Models Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 18 Mar 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Patient-derived Xenograft (PDX) Models market size was valued at USD 341.2 million in 2022 and is forecast to a readjusted size of USD 591.4 million by 2029 with a CAGR of 8.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global top 5 manufacturers of patient-derived xenograft (PDX) models occupied for a share nearly 45 percent, key players are Crown Bioscience, Champions Oncology, Wuxi Apptec, EPO Berlin-Buch, and Oncodesign, etc. Geographically speaking, Asia Pacific holds the most of global market share, about 35%. North America holds about 30% of share, while Europe followed by nearly 20%. In terms of type, mouse model accounted for nearly 75%, and rat model accounted for a share of 25%,The application of patient-derived xenograft (PDX) models includes preclinical drug development and biomarker analysis. Preclinical drug development shares over 75%, while biomarker analysis shares about 20%.

This report is a detailed and comprehensive analysis for global Patient-derived Xenograft (PDX) Models market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Patient-derived Xenograft (PDX) Models market size and forecasts, in consumption value ($ Million), 2018-2029
Global Patient-derived Xenograft (PDX) Models market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Patient-derived Xenograft (PDX) Models market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Patient-derived Xenograft (PDX) Models market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Patient-derived Xenograft (PDX) Models
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Patient-derived Xenograft (PDX) Models market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory and EPO Berlin-Buch, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Patient-derived Xenograft (PDX) Models market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Mouse Model
    Rat Model

Market segment by Application
    Preclinical Drug development
    Biomarker Analysis

Market segment by players, this report covers
    Crown Bioscience
    Champions Oncology
    Wuxi Apptec
    The Jackson Laboratory
    EPO Berlin-Buch
    Oncodesign
    Xentech
    Envigo
    Charles River Laboratories
    Pharmatest Services
    Urosphere
    MEDICILON
    Horizon Discovery
    Shanghai Model Organisms Center
    GemPharmatech
    LIDE Biotech

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Patient-derived Xenograft (PDX) Models product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Patient-derived Xenograft (PDX) Models, with revenue, gross margin and global market share of Patient-derived Xenograft (PDX) Models from 2018 to 2023.
Chapter 3, the Patient-derived Xenograft (PDX) Models competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Patient-derived Xenograft (PDX) Models market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Patient-derived Xenograft (PDX) Models.
Chapter 13, to describe Patient-derived Xenograft (PDX) Models research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Patient-derived Xenograft (PDX) Models
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Patient-derived Xenograft (PDX) Models by Type
        1.3.1 Overview: Global Patient-derived Xenograft (PDX) Models Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type in 2022
        1.3.3 Mouse Model
        1.3.4 Rat Model
    1.4 Global Patient-derived Xenograft (PDX) Models Market by Application
        1.4.1 Overview: Global Patient-derived Xenograft (PDX) Models Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Preclinical Drug development
        1.4.3 Biomarker Analysis
    1.5 Global Patient-derived Xenograft (PDX) Models Market Size & Forecast
    1.6 Global Patient-derived Xenograft (PDX) Models Market Size and Forecast by Region
        1.6.1 Global Patient-derived Xenograft (PDX) Models Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Patient-derived Xenograft (PDX) Models Market Size by Region, (2018-2029)
        1.6.3 North America Patient-derived Xenograft (PDX) Models Market Size and Prospect (2018-2029)
        1.6.4 Europe Patient-derived Xenograft (PDX) Models Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size and Prospect (2018-2029)
        1.6.6 South America Patient-derived Xenograft (PDX) Models Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Patient-derived Xenograft (PDX) Models Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Crown Bioscience
        2.1.1 Crown Bioscience Details
        2.1.2 Crown Bioscience Major Business
        2.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Product and Solutions
        2.1.4 Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Crown Bioscience Recent Developments and Future Plans
    2.2 Champions Oncology
        2.2.1 Champions Oncology Details
        2.2.2 Champions Oncology Major Business
        2.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Product and Solutions
        2.2.4 Champions Oncology Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Champions Oncology Recent Developments and Future Plans
    2.3 Wuxi Apptec
        2.3.1 Wuxi Apptec Details
        2.3.2 Wuxi Apptec Major Business
        2.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Product and Solutions
        2.3.4 Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Wuxi Apptec Recent Developments and Future Plans
    2.4 The Jackson Laboratory
        2.4.1 The Jackson Laboratory Details
        2.4.2 The Jackson Laboratory Major Business
        2.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product and Solutions
        2.4.4 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 The Jackson Laboratory Recent Developments and Future Plans
    2.5 EPO Berlin-Buch
        2.5.1 EPO Berlin-Buch Details
        2.5.2 EPO Berlin-Buch Major Business
        2.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product and Solutions
        2.5.4 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 EPO Berlin-Buch Recent Developments and Future Plans
    2.6 Oncodesign
        2.6.1 Oncodesign Details
        2.6.2 Oncodesign Major Business
        2.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Product and Solutions
        2.6.4 Oncodesign Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Oncodesign Recent Developments and Future Plans
    2.7 Xentech
        2.7.1 Xentech Details
        2.7.2 Xentech Major Business
        2.7.3 Xentech Patient-derived Xenograft (PDX) Models Product and Solutions
        2.7.4 Xentech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Xentech Recent Developments and Future Plans
    2.8 Envigo
        2.8.1 Envigo Details
        2.8.2 Envigo Major Business
        2.8.3 Envigo Patient-derived Xenograft (PDX) Models Product and Solutions
        2.8.4 Envigo Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Envigo Recent Developments and Future Plans
    2.9 Charles River Laboratories
        2.9.1 Charles River Laboratories Details
        2.9.2 Charles River Laboratories Major Business
        2.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Product and Solutions
        2.9.4 Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Charles River Laboratories Recent Developments and Future Plans
    2.10 Pharmatest Services
        2.10.1 Pharmatest Services Details
        2.10.2 Pharmatest Services Major Business
        2.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Product and Solutions
        2.10.4 Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Pharmatest Services Recent Developments and Future Plans
    2.11 Urosphere
        2.11.1 Urosphere Details
        2.11.2 Urosphere Major Business
        2.11.3 Urosphere Patient-derived Xenograft (PDX) Models Product and Solutions
        2.11.4 Urosphere Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Urosphere Recent Developments and Future Plans
    2.12 MEDICILON
        2.12.1 MEDICILON Details
        2.12.2 MEDICILON Major Business
        2.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Product and Solutions
        2.12.4 MEDICILON Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 MEDICILON Recent Developments and Future Plans
    2.13 Horizon Discovery
        2.13.1 Horizon Discovery Details
        2.13.2 Horizon Discovery Major Business
        2.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Product and Solutions
        2.13.4 Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Horizon Discovery Recent Developments and Future Plans
    2.14 Shanghai Model Organisms Center
        2.14.1 Shanghai Model Organisms Center Details
        2.14.2 Shanghai Model Organisms Center Major Business
        2.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product and Solutions
        2.14.4 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Shanghai Model Organisms Center Recent Developments and Future Plans
    2.15 GemPharmatech
        2.15.1 GemPharmatech Details
        2.15.2 GemPharmatech Major Business
        2.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Product and Solutions
        2.15.4 GemPharmatech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 GemPharmatech Recent Developments and Future Plans
    2.16 LIDE Biotech
        2.16.1 LIDE Biotech Details
        2.16.2 LIDE Biotech Major Business
        2.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Product and Solutions
        2.16.4 LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 LIDE Biotech Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Patient-derived Xenograft (PDX) Models Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Patient-derived Xenograft (PDX) Models by Company Revenue
        3.2.2 Top 3 Patient-derived Xenograft (PDX) Models Players Market Share in 2022
        3.2.3 Top 6 Patient-derived Xenograft (PDX) Models Players Market Share in 2022
    3.3 Patient-derived Xenograft (PDX) Models Market: Overall Company Footprint Analysis
        3.3.1 Patient-derived Xenograft (PDX) Models Market: Region Footprint
        3.3.2 Patient-derived Xenograft (PDX) Models Market: Company Product Type Footprint
        3.3.3 Patient-derived Xenograft (PDX) Models Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Patient-derived Xenograft (PDX) Models Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Patient-derived Xenograft (PDX) Models Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application (2018-2023)
    5.2 Global Patient-derived Xenograft (PDX) Models Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2029)
    6.2 North America Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2029)
    6.3 North America Patient-derived Xenograft (PDX) Models Market Size by Country
        6.3.1 North America Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2029)
        6.3.2 United States Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        6.3.3 Canada Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        6.3.4 Mexico Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2029)
    7.2 Europe Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2029)
    7.3 Europe Patient-derived Xenograft (PDX) Models Market Size by Country
        7.3.1 Europe Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2029)
        7.3.2 Germany Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        7.3.3 France Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        7.3.5 Russia Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        7.3.6 Italy Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Patient-derived Xenograft (PDX) Models Market Size by Region
        8.3.1 Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Region (2018-2029)
        8.3.2 China Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        8.3.3 Japan Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        8.3.4 South Korea Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        8.3.5 India Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        8.3.7 Australia Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2029)
    9.2 South America Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2029)
    9.3 South America Patient-derived Xenograft (PDX) Models Market Size by Country
        9.3.1 South America Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2029)
        9.3.2 Brazil Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        9.3.3 Argentina Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Patient-derived Xenograft (PDX) Models Market Size by Country
        10.3.1 Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2029)
        10.3.2 Turkey Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)
        10.3.4 UAE Patient-derived Xenograft (PDX) Models Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Patient-derived Xenograft (PDX) Models Market Drivers
    11.2 Patient-derived Xenograft (PDX) Models Market Restraints
    11.3 Patient-derived Xenograft (PDX) Models Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Patient-derived Xenograft (PDX) Models Industry Chain
    12.2 Patient-derived Xenograft (PDX) Models Upstream Analysis
    12.3 Patient-derived Xenograft (PDX) Models Midstream Analysis
    12.4 Patient-derived Xenograft (PDX) Models Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Patient-derived Xenograft (PDX) Models Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Patient-derived Xenograft (PDX) Models Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Patient-derived Xenograft (PDX) Models Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Patient-derived Xenograft (PDX) Models Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Crown Bioscience Company Information, Head Office, and Major Competitors
    Table 6. Crown Bioscience Major Business
    Table 7. Crown Bioscience Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 8. Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Crown Bioscience Recent Developments and Future Plans
    Table 10. Champions Oncology Company Information, Head Office, and Major Competitors
    Table 11. Champions Oncology Major Business
    Table 12. Champions Oncology Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 13. Champions Oncology Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Champions Oncology Recent Developments and Future Plans
    Table 15. Wuxi Apptec Company Information, Head Office, and Major Competitors
    Table 16. Wuxi Apptec Major Business
    Table 17. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 18. Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Wuxi Apptec Recent Developments and Future Plans
    Table 20. The Jackson Laboratory Company Information, Head Office, and Major Competitors
    Table 21. The Jackson Laboratory Major Business
    Table 22. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 23. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. The Jackson Laboratory Recent Developments and Future Plans
    Table 25. EPO Berlin-Buch Company Information, Head Office, and Major Competitors
    Table 26. EPO Berlin-Buch Major Business
    Table 27. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 28. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. EPO Berlin-Buch Recent Developments and Future Plans
    Table 30. Oncodesign Company Information, Head Office, and Major Competitors
    Table 31. Oncodesign Major Business
    Table 32. Oncodesign Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 33. Oncodesign Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Oncodesign Recent Developments and Future Plans
    Table 35. Xentech Company Information, Head Office, and Major Competitors
    Table 36. Xentech Major Business
    Table 37. Xentech Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 38. Xentech Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Xentech Recent Developments and Future Plans
    Table 40. Envigo Company Information, Head Office, and Major Competitors
    Table 41. Envigo Major Business
    Table 42. Envigo Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 43. Envigo Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Envigo Recent Developments and Future Plans
    Table 45. Charles River Laboratories Company Information, Head Office, and Major Competitors
    Table 46. Charles River Laboratories Major Business
    Table 47. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 48. Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Charles River Laboratories Recent Developments and Future Plans
    Table 50. Pharmatest Services Company Information, Head Office, and Major Competitors
    Table 51. Pharmatest Services Major Business
    Table 52. Pharmatest Services Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 53. Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Pharmatest Services Recent Developments and Future Plans
    Table 55. Urosphere Company Information, Head Office, and Major Competitors
    Table 56. Urosphere Major Business
    Table 57. Urosphere Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 58. Urosphere Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Urosphere Recent Developments and Future Plans
    Table 60. MEDICILON Company Information, Head Office, and Major Competitors
    Table 61. MEDICILON Major Business
    Table 62. MEDICILON Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 63. MEDICILON Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. MEDICILON Recent Developments and Future Plans
    Table 65. Horizon Discovery Company Information, Head Office, and Major Competitors
    Table 66. Horizon Discovery Major Business
    Table 67. Horizon Discovery Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 68. Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Horizon Discovery Recent Developments and Future Plans
    Table 70. Shanghai Model Organisms Center Company Information, Head Office, and Major Competitors
    Table 71. Shanghai Model Organisms Center Major Business
    Table 72. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 73. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Shanghai Model Organisms Center Recent Developments and Future Plans
    Table 75. GemPharmatech Company Information, Head Office, and Major Competitors
    Table 76. GemPharmatech Major Business
    Table 77. GemPharmatech Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 78. GemPharmatech Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. GemPharmatech Recent Developments and Future Plans
    Table 80. LIDE Biotech Company Information, Head Office, and Major Competitors
    Table 81. LIDE Biotech Major Business
    Table 82. LIDE Biotech Patient-derived Xenograft (PDX) Models Product and Solutions
    Table 83. LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. LIDE Biotech Recent Developments and Future Plans
    Table 85. Global Patient-derived Xenograft (PDX) Models Revenue (USD Million) by Players (2018-2023)
    Table 86. Global Patient-derived Xenograft (PDX) Models Revenue Share by Players (2018-2023)
    Table 87. Breakdown of Patient-derived Xenograft (PDX) Models by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 88. Market Position of Players in Patient-derived Xenograft (PDX) Models, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 89. Head Office of Key Patient-derived Xenograft (PDX) Models Players
    Table 90. Patient-derived Xenograft (PDX) Models Market: Company Product Type Footprint
    Table 91. Patient-derived Xenograft (PDX) Models Market: Company Product Application Footprint
    Table 92. Patient-derived Xenograft (PDX) Models New Market Entrants and Barriers to Market Entry
    Table 93. Patient-derived Xenograft (PDX) Models Mergers, Acquisition, Agreements, and Collaborations
    Table 94. Global Patient-derived Xenograft (PDX) Models Consumption Value (USD Million) by Type (2018-2023)
    Table 95. Global Patient-derived Xenograft (PDX) Models Consumption Value Share by Type (2018-2023)
    Table 96. Global Patient-derived Xenograft (PDX) Models Consumption Value Forecast by Type (2024-2029)
    Table 97. Global Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2023)
    Table 98. Global Patient-derived Xenograft (PDX) Models Consumption Value Forecast by Application (2024-2029)
    Table 99. North America Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2023) & (USD Million)
    Table 100. North America Patient-derived Xenograft (PDX) Models Consumption Value by Type (2024-2029) & (USD Million)
    Table 101. North America Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. North America Patient-derived Xenograft (PDX) Models Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. North America Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2023) & (USD Million)
    Table 104. North America Patient-derived Xenograft (PDX) Models Consumption Value by Country (2024-2029) & (USD Million)
    Table 105. Europe Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Europe Patient-derived Xenograft (PDX) Models Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Europe Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2023) & (USD Million)
    Table 108. Europe Patient-derived Xenograft (PDX) Models Consumption Value by Application (2024-2029) & (USD Million)
    Table 109. Europe Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Patient-derived Xenograft (PDX) Models Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2023) & (USD Million)
    Table 112. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Type (2024-2029) & (USD Million)
    Table 113. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2023) & (USD Million)
    Table 114. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Application (2024-2029) & (USD Million)
    Table 115. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Region (2018-2023) & (USD Million)
    Table 116. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value by Region (2024-2029) & (USD Million)
    Table 117. South America Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2023) & (USD Million)
    Table 118. South America Patient-derived Xenograft (PDX) Models Consumption Value by Type (2024-2029) & (USD Million)
    Table 119. South America Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2023) & (USD Million)
    Table 120. South America Patient-derived Xenograft (PDX) Models Consumption Value by Application (2024-2029) & (USD Million)
    Table 121. South America Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. South America Patient-derived Xenograft (PDX) Models Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Type (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Type (2024-2029) & (USD Million)
    Table 125. Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Application (2018-2023) & (USD Million)
    Table 126. Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Application (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Country (2018-2023) & (USD Million)
    Table 128. Middle East & Africa Patient-derived Xenograft (PDX) Models Consumption Value by Country (2024-2029) & (USD Million)
    Table 129. Patient-derived Xenograft (PDX) Models Raw Material
    Table 130. Key Suppliers of Patient-derived Xenograft (PDX) Models Raw Materials
List of Figures
    Figure 1. Patient-derived Xenograft (PDX) Models Picture
    Figure 2. Global Patient-derived Xenograft (PDX) Models Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type in 2022
    Figure 4. Mouse Model
    Figure 5. Rat Model
    Figure 6. Global Patient-derived Xenograft (PDX) Models Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application in 2022
    Figure 8. Preclinical Drug development Picture
    Figure 9. Biomarker Analysis Picture
    Figure 10. Global Patient-derived Xenograft (PDX) Models Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Patient-derived Xenograft (PDX) Models Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Market Patient-derived Xenograft (PDX) Models Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 13. Global Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Region (2018-2029)
    Figure 14. Global Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Region in 2022
    Figure 15. North America Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 16. Europe Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 17. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 18. South America Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 19. Middle East and Africa Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 20. Global Patient-derived Xenograft (PDX) Models Revenue Share by Players in 2022
    Figure 21. Patient-derived Xenograft (PDX) Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 22. Global Top 3 Players Patient-derived Xenograft (PDX) Models Market Share in 2022
    Figure 23. Global Top 6 Players Patient-derived Xenograft (PDX) Models Market Share in 2022
    Figure 24. Global Patient-derived Xenograft (PDX) Models Consumption Value Share by Type (2018-2023)
    Figure 25. Global Patient-derived Xenograft (PDX) Models Market Share Forecast by Type (2024-2029)
    Figure 26. Global Patient-derived Xenograft (PDX) Models Consumption Value Share by Application (2018-2023)
    Figure 27. Global Patient-derived Xenograft (PDX) Models Market Share Forecast by Application (2024-2029)
    Figure 28. North America Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type (2018-2029)
    Figure 29. North America Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application (2018-2029)
    Figure 30. North America Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Country (2018-2029)
    Figure 31. United States Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 32. Canada Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 33. Mexico Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 34. Europe Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type (2018-2029)
    Figure 35. Europe Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application (2018-2029)
    Figure 36. Europe Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Country (2018-2029)
    Figure 37. Germany Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 38. France Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 39. United Kingdom Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 40. Russia Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 41. Italy Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 42. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type (2018-2029)
    Figure 43. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application (2018-2029)
    Figure 44. Asia-Pacific Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Region (2018-2029)
    Figure 45. China Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 46. Japan Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 47. South Korea Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 48. India Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 49. Southeast Asia Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 50. Australia Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 51. South America Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type (2018-2029)
    Figure 52. South America Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application (2018-2029)
    Figure 53. South America Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Country (2018-2029)
    Figure 54. Brazil Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 55. Argentina Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 56. Middle East and Africa Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Type (2018-2029)
    Figure 57. Middle East and Africa Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Application (2018-2029)
    Figure 58. Middle East and Africa Patient-derived Xenograft (PDX) Models Consumption Value Market Share by Country (2018-2029)
    Figure 59. Turkey Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 60. Saudi Arabia Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 61. UAE Patient-derived Xenograft (PDX) Models Consumption Value (2018-2029) & (USD Million)
    Figure 62. Patient-derived Xenograft (PDX) Models Market Drivers
    Figure 63. Patient-derived Xenograft (PDX) Models Market Restraints
    Figure 64. Patient-derived Xenograft (PDX) Models Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Patient-derived Xenograft (PDX) Models in 2022
    Figure 67. Manufacturing Process Analysis of Patient-derived Xenograft (PDX) Models
    Figure 68. Patient-derived Xenograft (PDX) Models Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Patient-derived Xenograft (PDX) Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Patient-derived Xenograft (PDX) Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Patient-derived Xenograft (PDX) Models market size was valued at USD 341.2 million in 2023 and is forecast to a readjusted size of USD 591.4 million by 2030 with a CAGR of 8.2% during review period.

Product Tags

Patient-derived Xenograft (PDX) Models

Patient Derived Xenograft & PDX Models

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>